Kiora Pharmaceuticals, Inc. (KPRX) NASDAQ

3.24

+0.1158(+3.71%)

Updated at May 09 09:56AM

Currency In USD

Valuation

Market Cap12.78M
Enterprise Value9.04M
P/E Ratio2.6
PEG Ratio-0.04
Price/Sales Ratio0.59
Price/Book Ratio0.36
Enterprise/Revenue0.36
Enterprise/EBITDA0.97

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.22
Operating Margin0.29

Management Effectiveness

Return On Assets0.1
Return On Equity0.12

Income Statement

Revenue16.02M
Revenue/Share5.34
Gross Profit16M
EBITDA5.75M
Net Income3.59M
Diluted EPS0.87

Balance Sheet

Total Cash26.79M
Total Cash/Share8.93
Total Debt57,170
Total Debt/Equity0
Current Ratio4.94
Book Value Per Share8.58

Price History

52-Week Change-28.6
52-Week High5.55
52-Week Low2.51
Moving Average 50 Days3.07
Moving Average 200 Days3.48

Statistics

Average Volume20,806
Shares Outstanding3.04M
% Held by Institutions1.12

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:9
Last Split DateJune 11, 2024